Welcome to our dedicated page for MOLINA HEALTHCARE SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MOLINA HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MOLINA HEALTHCARE's regulatory disclosures and financial reporting.
Molina Healthcare, Inc. reported second quarter 2026 GAAP diluted EPS of $1.19 and adjusted diluted EPS of $1.51, as total revenue reached $10.9 billion. GAAP net income was $60 million, a 76% year‑over‑year decrease, with consolidated MCR at 92.2% versus 90.4% a year earlier.
Premium revenue was $10.2 billion, a 6% year‑over‑year decrease, on membership of about 4.9 million. Operating cash flow for the first half of 2026 was $788 million compared with a $112 million outflow a year earlier, and days in claims payable were 44.
The company reaffirmed full‑year 2026 premium revenue guidance of about $42 billion and increased GAAP EPS guidance to at least $2.15 and adjusted EPS to at least $5.25 per diluted share. Guidance includes an estimated loss of $1.50 per share from the new Florida Medicaid contract and $1.00 per share related to exiting the traditional MAPD product.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Director Richard C. Zoretic received a grant of 237 shares of Molina Healthcare common stock, awarded under the company’s 2025 Equity Incentive Plan for his board service. The award reflects a $55,000 quarterly portion of a $220,000 annual equity package, valued at a closing price of $232.55 per share. All 9,389 shares reported after the transaction are held indirectly through the Richard Charles Zoretic Revocable Living Trust.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received an equity grant of 237 shares of common stock, awarded through a trust, as part of his board compensation. The grant was made under the 2025 Equity Incentive Plan, valued at $55,000 based on the $232.55 closing price on July 1, 2026, bringing indirect holdings to 15,633 shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard M. Schapiro received a stock grant as part of his board compensation. He was awarded 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan, valued at $55,000 based on the closing price of $232.55 per share.
The filing explains this is one quarter of an annual equity award of $220,000 to each director, granted in four equal quarterly installments. Following this award, Schapiro directly holds 12,311 shares of Molina Healthcare common stock, reflecting ongoing, routine equity-based compensation for his service as a director.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received a stock grant through her revocable trust as part of routine board compensation. The trust was awarded 237 shares of common stock under the 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
This quarterly grant represents an equity value of $55,000, one quarter of a $220,000 annual equity award for directors. Following this award, the Ronna Romney Revocable Trust holds a total of 17,869 Molina Healthcare shares, reflecting ongoing compensation rather than an open-market purchase or sale.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant represents a quarterly equity award valued at $55,000, based on the $232.55 closing share price, as part of a $220,000 annual director equity package. Following this award, the trust holds 17,967 shares, and an additional 1,500 shares are held indirectly through Orlando’s 401(k) plan.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Stephen H. Lockhart received a stock award rather than making an open-market purchase. He was granted 237 shares of common stock on July 1, 2026 at a reference price of $232.55 per share under the company’s 2025 Equity Incentive Plan.
This grant represents one quarterly installment of an annual equity award valued at $220,000 for each director, with $55,000 granted on the first day of each quarter based on the closing share price that day. After this award, Lockhart directly holds 4,384 Molina Healthcare shares.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 237 shares of Common Stock on July 1, 2026 as compensation for his board service. The shares were issued under Molina Healthcare’s 2025 Equity Incentive Plan at a price of $232.55 per share, based on the closing market price that day.
This quarterly equity award represents one quarter of an annual director equity value of $220,000, with $55,000 granted each quarter. Following this grant, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.
SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock on July 1, 2026. The shares were awarded under the company’s 2025 Equity Incentive Plan as part of his director compensation, based on the stock’s closing price of $232.55.
The filing notes that each director’s annual equity award is valued at $220,000, with $55,000 granted on the first day of each quarter. Following this grant, Soistman directly holds 907 shares of Molina Healthcare common stock.